X @Forbes

The Multibillion-Dollar Battle For Metsera’s Obesity DrugsLearn how the battle between Novo Nordisk and Pfizer over Metsera, a three-year-old company working on treatments for obesity and diabetes, escalated this week. https://t.co/k1NQKNo2LG ...